May 07, 2013
Article
Evidence-Based Oncology
May 07, 2013
Article
Evidence-Based Oncology
May 07, 2013
Article
Evidence-Based Oncology
The cost-saving potential of specialty or disease-specific ACOs can be huge...but it is unclear whether these specialty services are more efficiently provided through their own ACO or as ancillary to the burgeoning primary care ACO marketplace.
May 07, 2013
Article
Evidence-Based Oncology
Market Dynamics Change How Plans Manage Oral and Office-Administered Agents
May 07, 2013
Article
Evidence-Based Oncology
As payment reform models continue to evolve, practitioners must determine which strategy makes the most sense for their practice. Although the idea behind bundled payments may be worth considering, there are some concerns that this system could causes disruptions in oncology practices.
May 07, 2013
Article
Evidence-Based Oncology